Sat, Aug 30, 2014, 4:56 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Ariad Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • timothyc121855 timothyc121855 Mar 16, 2012 9:38 AM Flag

    I don't know what to do now

    This is not a huge surprise. Institutional investors are long the stock for ponatinib---where ARIA owns 100% of drug for CML ($ 5 billion opportunity worldwide) where the data suggests that ARIA is best in class. This announcement relates to the product licensed to MRK---where it would have been nice to see positive data but not that big a story & much smaller part of the valuation story. The shorts will make noise on this news but institutional players involved in ARIA will buy up the sellers.

6.22+0.06(+0.97%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.